1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Experimental Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Judge, A; Maclachlan, I; McClintock, K; Phelps, JR | 1 |
Erickson, KL; Howard, AD | 1 |
Johnson, HM; Torres, BA | 1 |
Bajkowski, AS; Cavanaugh, PG; Honn, KV; Sloane, BF; Taylor, JD | 1 |
4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Experimental Neoplasms
Article | Year |
---|---|
Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes.
Topics: Animals; Antibody Formation; Drug Delivery Systems; Hypersensitivity; Liposomes; Male; Mice; Mice, Inbred A; Mice, Inbred BALB C; Mice, Inbred ICR; Neoplasms, Experimental; Platelet Activating Factor; Polyethylene Glycols; Vaccines, DNA | 2006 |
The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
Topics: Animals; Cytotoxicity, Immunologic; Dose-Response Relationship, Immunologic; Female; Macrophage Activation; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Nitric Oxide; Platelet Activating Factor; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1995 |
Mechanism of calcium ionophore A23187-induced priming of bone marrow-derived macrophages for tumor cell killing: relationship to priming by interferon.
Topics: Animals; Bone Marrow Cells; Calcimycin; Cytotoxicity, Immunologic; Diglycerides; Dose-Response Relationship, Drug; Interferons; Lipopolysaccharides; Macrophages; Male; Mice; Neoplasms, Experimental; Phorbols; Platelet Activating Factor; Tetradecanoylphorbol Acetate | 1985 |
Purification and characterization of platelet aggregating activity from tumor cells: copurification with procoagulant activity.
Topics: Animals; Blood Coagulation; Blood Coagulation Factors; Coagulants; Lipids; Mice; Neoplasms, Experimental; Platelet Activating Factor; Platelet Aggregation; Protease Inhibitors | 1985 |